(BPT) - People living with a chronic condition may experience stigmatization on a daily basis. Diane Talbert can relate; a patient-turned-advocate, she has fought her own battle with plaque psoriasis
(BPT) - People living with a chronic condition may experience stigmatization on a daily basis. Diane Talbert can relate; a patient-turned-advocate, she has fought her own battle with plaque psoriasis
/PRNewswire/ AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of.
/PRNewswire/ AbbVie (NYSE: ABBV) today announced the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for the treatment of.
RINVOQ® (upadacitinib) Receives U S FDA Approval for Active Psoriatic Arthritis streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.